Leiden University Scholarly Publications

Persistent URL of this record https://hdl.handle.net/1887/116820

Beta release

Statistics of Incremental Benefit of Open-Label Certolizumab Pegol plus MTX in Rheumatoid Arthritis (RA) Patients Following Double-Blind Placebo plus IVITX Treatment Out to 2 Years
Statistics for this year
PeriodVisitsDownloads
202400
Statistics for the last 3 months
PeriodVisitsDownloads
2024-0900
2024-1000
2024-1100